A Bio-Mathematical Model for Parallel Organs and its use in Ranking Radiation Treatment Plans (583-590)

To develop a new bio-mathematical model, named LQ-based parallel-organ model, that can overcome the limitation of interpreting the simple dose-volume information so as to rank the radio- toxicity of parallel organs in the same patient. A parallel organ consists of Function Subunits (FSUs), with each FSU being equal and representative in functional status. Based on the Linear-Quadratic model (LQ model), we had derived a bio-mathematical model to calculate the survival cell number for radiation dose response. We then compared the cell survival number for the ranking of treatment plans for the same patient. Ninety 3D plans from forty-five randomly selected lung cancer patients were generated using the ELEKTA precise 2.12 treatment planning system. The LQ-based parallel-organ model was tested against the widely used Lyman-Kutcher-Burman model (LKB model). There was no distinct statistical difference in plan ranking between using the LQ-based parallel-organ model and the LKB model (P = 0.475). Ranking plans by the Vx, Mean Lung Dose (MLD) and the LQ-based parallel-organ model shows that there was no distinct statistical difference between V5, V10, V20, MLD and the LQ-based parallel-organ model, respectively (all Ps > 0.05). The proposed LQ-based parallel-organ model was found to be efficient and reliable for ranking treatment plans for the same patient.

Key words: Bio-Mathematical model; Parallel organs; Cell survival numbers; Ranking.

DOI: 10.7785/tcrt.2012.500273

Li Wang, M.M.1,2
Wenhui Li, M.D.1,2*
Han Bai, Ph.M.1,2
Li Chang, M.D.1,2
Jiyong Qin, M.B.1,2
Yu Hou, M.M.1,2

1Radiation Oncology Center, Yunnan Tumor Hospital, Kunming, Yunnan, China
2Radiation Oncology Center, The Third Affiliated Hospital of Kunming Medical College, Kunming, Yunnan, China

*Corresponding author:
Wenhui Li, M.D.
E-mail: bh001925@163.com

This article can be cited as: Wang, L., Li, W., Bai, H., Chang, L., Qin, J., Hou, Y. A Bio-Mathematical Model for Parallel Organs and its use in Ranking Radiation Treatment Plans Technol Cancer Res Treat. 11 583-590, (2012)

This article can be accessed at PubMed:
http://www.ncbi.nlm.nih.gov/pubmed/22775336

References

1. Saito, T., Sakamoto, T., Oya, N. Comparison of gating around end-expiration and end-inspiration in radiotherapy for lung cancer. Radiother Oncol 93, 430-435 (2009). [Crossref]
2. Wang, S., Liao, Z., Wei, X. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66, 1399-1407 (2006). [Crossref]
3. Kadoya, N., Obata, Y., Kato, T. Dose-Volume Comparison of Proton Radiotherapy and Stereotactic Body Radiotherapy for Non-Small-Cell Lung Cancer. Int J Radiat Oncol Biol Phys 79, 1225-1231(2011). [Crossref]
4. Saito, T., Sakamoto, T., Oya, N. Predictive factors for lung dose reduction by respiratory gating at radiotherapy for lung cancer. J Radiat Res (Tokyo) 51, 691-698 (2010). [Crossref]
5. Dang, J., Li, G., Lu, X., Yao, L., Zhang, S., Yu, Z. Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. J Cancer Res Clin Oncol 136, 1169-1178 (2010). [Crossref]
6. Wennberg, B. M., Baumann, P., Gagliardi, G., Nyman, J., Drugge, N., Hoyer, M., Traberg, A., Nilsson, K., Morhed, E., Ekberg, L., Wittgren, L., Lund, J. A., Levin, N., Sederholm, C., Lewensohn, R., Lax, I. NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction. Acta Oncol 50, 518-527 (2011). [Crossref]
7. Liu, H. H., Wang, X., Dong, L., Wu, Q., Liao, Z., Stevens, C. W., Guerrero, T. M., Komaki, R., Cox, J. D., Mohan, R. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58, 1268-1279 (2004). [Crossref]
8. Rutkowska, E., Baker, C., Nahum, A. Mechanistic simulation of normal-tissue damage in radiotherapy implications for dose-volume analyses. Phys Med Biol 55, 2121-2136 (2010). [Crossref]
9. Menegakis, A., Yaromina, A., Eicheler, W., Dorfler, A., Beuthien-Baumann, B., Thames, H. D., Baumann, M., Krause, M. Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by gammaH2AX staining. Int J Radiat Biol 85, 1032-1041 (2009). [Crossref]
10. McKenna, F. W., Ahmad, S. Fitting techniques of cell survival curves in high-dose region for use in stereotactic body radiation therapy. Phys Med Biol 54, 1593-1608 (2009). [Crossref]
11. Alsbeih, M. G., Fertil, B., Badie, C., Malaise, E. P. The beta component of human cell survival curves and its relationship with split-dose recovery. Int J Radiat Biol 67, 453-460 (1995).
12. Puck, T. T., Marcus, P. Action of X-rays on mammalian cells. J Exp Med 103, 653-666 (1956).
13. Peack, J. H., De Almodovar, M. R., McMillan, T. J., Steel, G. G. The nature of the initial slope of radiation cell survival curves. Br J Radiol 24, 57-60 (1992).
14. Carlone, M., Wilkins, D., Raaphorst, P. The modified linear-quadratic model of Guerrero and Li can be derived from a mechanistic basis and exhibits linear-quadratic-linear behaviour. Phys Med Biol 50, 9-13 (2005). [Crossref]
15. Guerrero, M., Li, X. A. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol 49, 4825-4835 (2004). [Crossref]
16. Garcia, L. M., Leblanc, J., Wilkins, D., Raaphorst, G. P. Fitting the linear-quadratic model to detailed data sets for different dose ranges. Phys Med Biol 51, 2813-2823 (2006). [Crossref]
17. Bromley, R., Oliver, L., Davey, R., Harvie, R., Baldock, C. Predicting the clonogenic survival of A549 cells after modulated x-ray irradiation using the linear quadratic model. Phys Med Biol 54, 187-206 (2009). [Crossref]
18. Barendsen, G. W. Parameters of linear-quadratic radiation dose-effect relationships: dependence on LET and mechanisms of reproductive cell death. Int J Radiat Biol 71, 649-655 (1997). [Crossref]
19. Schell, S., Wilkens, J. J., Oelfke, U. Radiobiological effect based treatment plan optimization with the linear quadratic model. Z Med Phys 20, 188-196 (2010).
20. Marchese, M. J., Zaider, M., Hall, E. J. Dose-rate effects in normal and malignant cells of human origin. Br J Radiol 60, 573-576 (1987).
21. Dubray, B., Henry-Amar, M., Meerwaldt, J. H., Noordijk, E. M., Dixon, D. O., Cosset, J. M., Thames, H. D. Radiation-induced lung damage after thoracic irradiation for Hodgkin’s disease: the role of fractionation. Radiother Oncol 36, 211-217 (1995). [Crossref]
22. Luxton, G., Keall, P. J., King, C. R. A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD). Phys Med Biol 53, 23-36 (2008). [Crossref]
23. Niemierko, A. A generalized concept of equivalent uniform dose (EUD). Med Phys 26, 1100 (1999).
24. Choi, B., Deasy, J. O. The generalized equivalent uniform dose function as a basis for intensity modulated treatment planning. Phys Med Biol 47, 3579-3589 (2002). [Crossref]
25. Lyman, J. T. Complication probability as assessed from Dose volume histograms Radiat Res 104, 13-19 (1985).
26. Yu, X., Prosnitz, R. R., Zhou, S., Hardenberg, P. H., Tisch, A., Blazing, M. A., Borges-Neto, S., Hollis, D., Wong, T., Marks, L. B. Symptomatic cardiac events following radiation therapy for left-sided breast cancer: possible association with radiation therapy-induced changes in regional perfusion. Clin Breast Cancer 4, 193-197 (2003).
27. Marks, L. B., Yu, X., Prosnitz, R. G., Zhou, S. M., Hardenbergh, P. H., Blazing, M., Hollis, D., Lind, P., Tisch, A., Wong, T. Z., Borges-Neto, S. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys 63, 214-223 (2005). [Crossref]
28. Hardenbergh, P. H., Munley, M. T., Bentel, G. C., Kedem, R., Borges-Neto, S., Hollis, D., Prosnitz, L. R., Marks, L. B. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys 49, 1023-1028 (2001). [Crossref]
29. Graham, M. V., Purdy, J. A., Emami, B., Harms, W., Bosch, W., Lockett, M. A., Perez, C. A. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45, 323-329 (1999). [Crossref]
30. Schallenkamp, J. M., Miller, R. C., Brinkmann, D. H., Foote, T., Garces, Y. I. Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates. Int J Radiat Oncol Biol Phys 67, 410-416 (2007). [Crossref]
31. Wang, S., Liao, Z., Wei, X., Liu, H. H., Tucker, S. L., Hu, C. S., Mohan, R., Cox, J. D., Komaki, R. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66, 1399-1407 (2006). [Crossref]
32. Allen, A. M., Czerminska, M., Janne, P. A., Sugarbaker, D. J., Bueno, R., Harris, J. R., Court, L., Baldini, E. H. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 65, 640-645 (2006). [Crossref]
33. Marks, L. B., Spencer, D. P., Sherouse, G. W., Bentel, G., Clough, R., Vann, K., Jaszczak, R., Coleman, R. E., Prosnitz, L. R. The role of three dimensional functional lung imaging in radiation treatment planning: the functional dose-volume histogram. Int J Radiat Oncol Biol Phys 33, 65-75 (1995). [Crossref]
34. Rancati, T., Ceresoli, G. L., Gagliardi, G., Schipani, S., Cattaneo, G. M. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 67, 275-283 (2003). [Crossref]
35. Piotrowski, T., Matecka-Nowak, M., Milecki, P. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy. Neoplasma 52, 56-62 (2005).
36. Rogers, P. B., Plowman, P. N., Harris, S. J., Arlett, C. F. Four radiation hypersensitivity cases and their implications for clinical radiotherapy. Radiother Oncol 57, 143-154 (2000). [Crossref]
37. Yin, W. B., Yu, Z. H., Xu, G. Z., Hu, Y. M. Radiation Oncology, BeiJing, 237 (2008).
38. Hope, A. J., Lindsay, P. E., Naqa, I., Alaly, J. R., Vicic, M., Bradley, J. D., Deasy, J. O. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys 65, 112-124 (2006). [Crossref]
39. Rabbani, Z. N., Anscher, M. S., Zhang, X., Chen, L., Samulski, T. V., Li, C. Y., Vujaskovic, Z. Soluble TGFbeta type II receptor gene therapy ameliorates acute radiation-induced pulmonary injury in rats. Int J Radiat Oncol Biol Phys 57, 563-572 (2003). [Crossref]
40. Arpin, D., Perol, D., Blay, J. Y., Falchero, L., Claude, L., Vuillermoz-Blas, S., Martel-Lafay, I., Ginestet, C., Alberti, L., Nosov, D. Etienne-Mastroianni, B., Cottin, V., Perol, M., Guerin, J. C., Cordier, J. F., Carrie, C. Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol 23, 8748-8756 (2005). [Crossref]
41. Mavroidis, P., Plataniotis, G. A., Gorka, M. A., Lind, B. K. Comments on ‘Reconsidering the definition of a dose-volume ­histogram’—dose-mass histogram (DMH) versus dose-volume histogram (DVH) for predicting radiation-induced pneumonitis. Phys Med[Crossref]

Purchase Downloadable Article

Corporate Library

$100.00

University/Academic User

$50.00

Member Login | Home | Editorial Board | Instructions | Subscribe | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Mountain Media ecommerce solutions Ecommerce Solutions by Mountain Media